Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease

INTRODUCTION: This study assessed the utility of cerebrospinal fluid (CSF) neurofilament light (NfL) in Alzheimer's disease (AD) diagnosis, its association with amyloid and tau pathology, as well as its potential to predict brain atrophy, cognition, and amyloid accumulation. METHODS: CSF NfL co...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Alzheimers Dement (Amst)
Autors principals: Dhiman, Kunal, Gupta, Veer Bala, Villemagne, Victor L., Eratne, Dhamidhu, Graham, Petra L., Fowler, Christopher, Bourgeat, Pierrick, Li, Qiao‐Xin, Collins, Steven, Bush, Ashley I., Rowe, Christopher C., Masters, Colin L., Ames, David, Hone, Eugene, Blennow, Kaj, Zetterberg, Henrik, Martins, Ralph N.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Cerebrospinal Fluid Biomarkers
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7085283/
https://ncbi.nlm.nih.gov/pubmed/32211500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/dad2.12005
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars